0001209191-18-038984.txt : 20180621
0001209191-18-038984.hdr.sgml : 20180621
20180621172023
ACCESSION NUMBER: 0001209191-18-038984
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180620
FILED AS OF DATE: 20180621
DATE AS OF CHANGE: 20180621
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LASEZKAY GEORGE M
CENTRAL INDEX KEY: 0001020514
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37783
FILM NUMBER: 18912534
MAIL ADDRESS:
STREET 1: 1301 SECOND AVE., SUITE 4200
CITY: SEATTLE
STATE: WA
ZIP: 98101
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Clearside Biomedical, Inc.
CENTRAL INDEX KEY: 0001539029
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 452437375
STATE OF INCORPORATION: GA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 900 NORTH POINT PARKWAY
STREET 2: SUITE 200
CITY: ALPHARETTA
STATE: 2Q
ZIP: 30005
BUSINESS PHONE: 678-270-3631
MAIL ADDRESS:
STREET 1: 900 NORTH POINT PARKWAY
STREET 2: SUITE 200
CITY: ALPHARETTA
STATE: 2Q
ZIP: 30005
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-06-20
0
0001539029
Clearside Biomedical, Inc.
CLSD
0001020514
LASEZKAY GEORGE M
C/O CLEARSIDE BIOMEDICAL, INC.
900 NORTH POINT PARKWAY, SUITE 200
ALPHARETTA
GA
30005
1
0
0
0
Stock Option (right to buy)
10.74
2018-06-20
4
A
0
11250
0.00
A
2028-06-19
Common Stock
11250
11250
D
The shares underlying this option vest in full on the earlier of the Issuer's next annual meeting of stockholders or June 20, 2019.
/s/ Brian F. Leaf, Attorney-in-Fact
2018-06-21